Emulating on SMi's successful PFS series, they are bringing this must-attend event to the West Coast, where they will focus more on the innovative technologies. Join them today to discuss with your industry colleagues to accelerate PFS development.
Through practical case studies from pharma and interactive discussions, you will:
- Learn about the A-Z of extractables and leachables to ensure a holistic PFS safety assessment
- Keep your patients at heart: embedding human factors into device design
- Update on new PFS material selection and innovation in device design for combination products
- Understand regulators expectations and adhere to strict visual and PFS manufacturing inspection standards
- Discuss, debate and benchmark against peers' best practice to stay ahead of the competition
SPEAKER PANEL INCLUDES:
- Dr. Ed Israelski, Former Director Human Factors, Abbvie; Co-Convener, ISO/IEC Joint Working Group on Usability Standards for Medical Devices
- Jeffrey Givand, Director – Device Development, Merck, Sharp and Dohme Corp
- Suzette Roan, Associate Director, Regulatory Affairs CMC Combination Products, Biogen
- Benir Ruano, Vice President, Global Manufacturing and Technical Operations, Xeris Pharmaceuticals, Inc
- Lisa Nilsson, Human Factors Manager, Teva
- Shun Ogawa, Research Manager, Mitsubishi Gas Chemical Company, Inc
- Toshiro Katayama, Product Manager, Zeon Chemicals L.P
- Kevin Constable, Senior Director of Technology Development, Terumo
- Senior Representative, Noxilizer and many more
WHO SHOULD ATTEND
Selected audience include but are not limited to those working in the pharmaceutical, biotech and medical device industry with responsibilities in manufacturing, packaging, supply chain, device development and regulatory affairs.
SVP, VP, Chief, Director, Head, Principal of
- Prefilled Syringes
- Drug Delivery
- Device Development
- Global Product Management
- Human Factors
- Application/ Device Specialists
Prices:
Standard Price: USD 1799
Early Bird Price - book by Feb 29: USD 1399
Early Bird Price - book by March 31: USD 1499